A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis.

Abstract

OBJECTIVES To compare the efficacy and safety of dienogest at doses of 1, 2, and 4mg/day orally in the treatment of endometriosis. METHODS An open-label, randomized, multicenter, 24-week comparative trial in women with histologically confirmed endometriosis. Efficacy was assessed by second-look laparoscopy and patient-reported symptoms. Statistical tests… (More)
DOI: 10.1016/j.ijgo.2009.08.020

Topics

Cite this paper

@article{Khler2010ADS, title={A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis.}, author={G{\"{u}nter K{\"{o}hler and Thomas A Faustmann and Christoph Gerlinger and Christian Seitz and Alfred Otto Mueck}, journal={International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics}, year={2010}, volume={108 1}, pages={21-5} }